ask="2.60"
ask_size="600"
average_daily_volume="548705"
bid="2.35"
bid_size="1500"
book_value="1.37"
change="-0.10"
change_from_200_day_moving_average="-0.76"
change_from_50_day_moving_average="-0.11"
change_from_52_week_high="-6.50"
change_From_52_week_low="0.28"
change_in_percent="-4.00%"
close="2.40"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.31"
ebitda="-61.52M"
eps_estimate_current_year="-1.55"
eps_estimate_next_quarter="-0.38"
eps_estimate_next_year="-1.42"
ex_dividend_date="N/A"
float_shares="36032000"
high="2.55"
high_52_weeks="8.90"
last_trade_date="1/5/2017"
last_trade_price="2.40"
last_trade_size="5477"
last_trade_time="4:00pm"
low="2.35"
low_52_weeks="2.12"
market_capitalization="127.02M"
moving_average_200_day="3.16"
moving_average_50_day="2.51"
name="Regulus Therapeutics Inc."
notes="N/A"
one_year_target_price="8.60"
open="2.50"
pe_ratio="N/A"
peg_ratio="-0.04"
percent_change_from_200_day_moving_average="-24.02%"
percent_change_from_50_day_moving_average="-4.51%"
percent_change_from_52_week_high="-73.03%"
percent_change_from_52_week_low="+12.94%"
previous_close="2.50"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.82"
price_per_sales="10.99"
revenue="12.04M"
shares_outstanding="52923000"
short_ratio="6.08"
stock_exchange="NGM"
symbol="RGLS"
volume="684184"
weeks_range_52="2.12 - 8.90"
